NovaQuest Capital Management Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, NovaQuest Capital Management has acquired 6 companies. It has also invested in 3 others.

NovaQuest Capital Management’s most common sectors for investment are life science (60%) and information technology (20%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (50%) and growth capital (30%). In total, NovaQuest Capital Management has invested in 5 US states and 2 different countries.

In the last 3 years, NovaQuest Capital Management has exited 2 companies. The Firm’s most common exit type is buyout (lbo, mbo, mbi) (50%).

Join Mergr to view NovaQuest Capital Management’s full profile and discover more large private equity firms just like it.

M&A Summary

  • M&A Total Activity11
    • M&A Buy Activity9
    • M&A Sell Activity2
  • Total Sectors Invested 4
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2
  • M&A Advisors 2

NovaQuest Capital Management

4208 Six Forks Road Suite 920,
Raleigh, North Carolina 27609
United States
(919) 459-8620
www.novaquest.com
melinda.grill-feder@nqcapital.com

NovaQuest Capital Management is a private equity firm focused on acquiring and investing in growth-stage middle-market healthcare companies. Specific areas of interest include life science, medical technology, healthcare/facility services, and healthcare focused IT. The Firm targets profitable companies valued up to $500 million with $20 to $100 million of revenue. NovaQuest Capital Management was established in 2000 and is based in Raleigh, North Carolina.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital

Geographic Preferences: East US, Midwest US, South US, West US, Canada

Transaction Criteria Min Max
Target Revenue 20 100
Target EBITDA - -
Investment Size - -
Enterprise Value - 500
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.6/yr) # 1 - 4 1 1 2 9
Sell (0.4/yr) # - - 1 - 1 - 2
  11

Most Recent M&A

Company Date Value Type
Pro-ficiency 2021-02-23 - Growth Capital
Durham, North Carolina · www.pro-ficiency.com
CoreRx, Inc. 2021-01-19 - Buyout (LBO, MBO, MBI)
Clearwater, Florida · www.corerxpharma.com
Mileutis Ltd. 2020-10-19 - Growth Capital
Ness Ziona, Israel · www.mileutis.com
Clinical Ink, Inc. 2020-08-04 - Secondary Buyout
Horsham, Pennsylvania · www.clinicalink.com
InformedDNA 2019-12-23 - Growth Capital
St Petersburg, Florida · www.informeddna.com
Catalyst Clinical Research LLC 2018-10-31 - Buyout (LBO, MBO, MBI)
Durham, North Carolina · www.catalystcr.com
California Cryobank LLC 2018-06-15 - Buyout (LBO, MBO, MBI)
Los Angeles, California · www.californiacryobank.com
Clinical Ink, Inc. 2018-05-14 - Buyout (LBO, MBO, MBI)
Horsham, Pennsylvania · www.clinicalink.com
Azurity Pharmaceuticals, Inc. 2018-03-26 - Secondary Buyout
Woburn, Massachusetts · www.cutispharma.com
Viamet Pharmaceuticals, Inc. 2018-01-03 - Buyout (LBO, MBO, MBI)
Durham, North Carolina · www.viamet.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 5 (63%) - 6 (60%) -
Information Technology 1 (13%) - 2 (20%) -
Education 1 (13%) - 1 (10%) -
Staffing 1 (13%) - 1 (10%) -
Total 8 - 10 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 7 (88%) - 9 (90%) -
  North Carolina 3 (38%) - 3 (30%) -
  Florida 2 (25%) - 2 (20%) -
  Pennsylvania 1 (13%) - 2 (20%) -
  Massachusetts 1 (13%) - 1 (10%) -
  California - - 1 (10%) -
Israel 1 (13%) - 1 (10%) -
Total 8 - 10 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 3 (38%) - 5 (50%) -
Growth Capital 3 (38%) - 3 (30%) -
Secondary Buyout 2 (25%) - 2 (20%) -
Total 8 - 10 -

Exits by Deal Type

Type Total # Value
Secondary Sale 2 (100%) -
Total 2 -

Top M&A Advisors

Legal Deals
Wyrick Robbins Yates & Ponton LLP
2
Bass, Berry & Sims PLC
1

M&A Connections

Deals
Acquired from
Investor(s)
20%
2 (20%)
Strategic(s)
10%
1 (10%)
Exited to
Investor(s)
100%
2 (100%)

 Subscribe to unlock this and 161,149
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 150K M&A Transactions
  • 157K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 48K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.